Health and Healthcare
Health and Healthcare Articles
Truist Securities initiated CorMedix with a Buy rating and a $20 price target. The stock closed below $5 a share on Friday.
Published:
Precision oncology company PMV Pharmaceuticals intends to price more than 7.35 million shares for an initial public offering valued up to around $152 million.
Published:
The Centers for Disease Control (CDC) has changed its rule about who should get COVID-19 testing. Most recently, it backtracked on a rule. For a period, the rules said people who came in contact with...
Published:
As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple of weeks, firms working toward this goal have taken steps forward and back, which...
Published:
According to the Centers for Disease Control and Prevention, Mississippi had the highest level of obesity last year. Most of the states with the highest obesity rates are south of the Mason-Dixon...
Published:
Gilead Sciences would not be the first company to pile on more debt to make an acquisition, but it is now eating deep into its cash for this acquisition.
Published:
Cancer-detection-focused health care company Grail has filed with the SEC, regarding its initial public offering.
Published:
Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) has announced that it will push forward with a midstage trial in the treatment of COVID-19.
Published:
Sorrento Therapeutics shares jumped on Thursday after the company announced that it received approval from the FDA for its COVID-19 treatment.
Published:
Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares rallied on the news early Wednesday.
Published:
Last Updated:
On Tuesday, Canaccord Genuity reiterated its rating on Atara Biotherapeutics and raised its wildly bullish target price even higher.
Published:
The announcement of positive topline results in a late-stage epilepsy trial prompted a rally in Marinus Pharmaceuticals shares on Tuesday.
Published:
Companies winning approval from the FDA or beating a trial are expected in some cases. If investors already have priced this news into the stock, when it actually comes around they tend to sell the...
Published:
These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
Published:
When 30 million confirmed COVID-19 cases globally are reached later this week, there will be a suspicion that the number is not even close to reality.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.